Abstract
Atrial fibrillation (AF) is a frequent complication of acute coronary syndrome (ACS) and is associated with an increased risk of in-hospital and long-term mortality. Yet, many studies lack recurrent electrocardiographic (ECG) assessments in hospital and core-lab verification of AF, which is important for accurate prognostication. The purpose of this study was to determine whether patients presenting with ACS who developed new-onset AF had an increased risk of death or a composite major adverse cardiovascular endpoint (MACE) of death, myocardial (re)infarction (MI), or stroke when compared to patients with and without prior AF.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
